September 13, 2019 / 1:25 PM / 2 months ago

BUZZ-U.S. STOCKS ON THE MOVE-Broadcom, Biogen, Bitauto, Akari Therapeutics

* Eikon search string for individual stock moves:

* The Day Ahead newsletter: tmsnrt.rs/2ggOmBi

* The Morning News Call newsletter: tmsnrt.rs/2fwPLTh U.S. stocks were set to open higher for the third straight day on Friday on growing optimism around trade talks between the United States and China as well as stronger-than-expected domestic retail sales.

At 9:05 a.m. ET, Dow e-minis were up 0.24% at 27,264. S&P 500 e-minis were up 0.14% at 3,016, while Nasdaq 100 e-minis were down 0.03% at 7,919.25. The top three NYSE percentage gainers premarket: ** Vince Holding Corp, up 19.2% ** Mallinckrodt, up 13.7% ** Bitauto Holdings Ltd, up 12.3% The top three NYSE percentage losers premarket: ** Sculptor Capital Management Inc, down 52.2% ** Ra Medical Systems Inc, down 7.1% ** Progressive Corp, down 3.9% The top three Nasdaq percentage gainers premarket: ** Mer Telemanagement Solutions Ltd, up 108.3% ** Fibrocell Science Inc, up 60.0% ** Senestech Inc, up 16.9% The top three Nasdaq percentage losers premarket: ** Ritter Pharmaceuticals Inc, down 72.1% ** Quotient Ltd, down 12.9% ** Ardelyx Inc, down 10.8% ** Broadcom Inc: down 1.1% premarket BUZZ-Falls after narrow revenue miss ** LightPath Technologies Inc: down 6.3% premarket BUZZ-Tariffs on Chinese goods hurt results ** Ritter Pharmaceuticals Inc: down 72.1% premarket BUZZ-Plunge as lactose intolerance therapy fails trial ** Park Hotels & Resorts Inc: up 2.6% premarket BUZZ-Set to join S&P Midcap 400 following Chesapeake Lodging buy ** Fibrocell Science Inc: up 60.0% premarket BUZZ-Shares rally after buyout deal ** Zynga Inc: down 0.5% premarket BUZZ-Shares slip on security breach incident ** Biogen Inc: down 0.6% premarket BUZZ-Shares slip as company, Eisai discontinue two more Alzheimer’s trials ** Bitauto Holdings: up 12.3% premarket BUZZ-Soars on go-private offer ** Etsy Inc: up 3.0% premarket BUZZ-Rises as Wedbush sees promise in ads and free shipping ** Akari Therapeutics: up 11.3% premarket BUZZ-At 2-week high on orphan drug designation for rare skin disease (Compiled by Ayanti Bera in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below